The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
FORTEO teriparatide (rbe) 250 microgram solution for injection cartridge, Eli Lilly Australia Pty Ltd, CON-1219
Product name
FORTEO teriparatide (rbe) 250 microgram solution for injection cartridge
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1219
Duration
The consent is effective from 22 March 2024 until 31 March 2025.
Standard
paragraph 8 (1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product labels do not include the current address for the sponsor, and say
North Ryde, NSW in place of Sydney, NSW
Therapeutic product type
Prescription medicines